BioRender recognizes the paramount importance of safeguarding the sensitive data our users trust us with and maintaining the privacy of our users. We strive to hold the highest standards of data privacy and security for the benefit of the global scientific community. As part of our commitment to data privacy and security, we have established this dedicated Trust Center, which serves as a comprehensive resource for those seeking to learn more about our security and privacy program. Within the Trust Center, individuals can request access to detailed reports and program specifics, demonstrating our dedication to transparency and accountability in all aspects of our operations.
- Can you provide the institution documentation regarding the retention period for those logs, how logs are protected, and whether they are accessible to the customer (and if so, how)?
- At the completion of this contract, will data be returned to the institution and/or deleted from all your systems and archives?
- Can you provide a current, detailed accessibility roadmap with delivery timelines?
- Does your solution process GDPR-related or PIPL-related data?
- Do you share any institutional data with law enforcement without a valid warrant or subpoena?
Trust Center Updates
CVE-2026-31431
BioRender (Science Suite Inc.) has assessed CVE-2026-31431, a Linux kernel local privilege escalation vulnerability recently disclosed with a CVSS score of 7.8.
BioRender has completed its assessment of this vulnerability across our infrastructure and confirmed that appropriate mitigations are in place. Remediation was carried out in accordance with our vulnerability management policy, which prioritizes high and critical severity findings for rapid response.
BioRender continuously monitors the threat landscape and maintains a proactive patching cadence to protect the confidentiality, integrity, and availability of customer data.


